BridgeBio Pharma Inc. (BBIO)
BridgeBio Pharma Max Pain By Strike
BBIO trades at $50.23, 11.6% above the near-term max pain of $45 expiring Sep 19, 2025 (28 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($20-$50), indicating stable market expectations. Key magnetic zone at 50 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
BridgeBio Pharma Max Pain By Expiry
Max pain for BBIO shows stable levels around 41.07, reflecting balanced market expectations. The 73% spread signals divergent expectations across timeframes. Most levels below 50.23 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 45 | -5.23 (-10.41%) |
| Oct 17, 2025 | 47.5 | -2.73 (-5.43%) |
| Nov 21, 2025 | 40 | -10.23 (-20.37%) |
| Jan 16, 2026 | 35 | -15.23 (-30.32%) |
| Feb 20, 2026 | 50 | -0.23 (-0.46%) |
| Jul 17, 2026 | 50 | -0.23 (-0.46%) |
| Jan 15, 2027 | 20 | -30.23 (-60.18%) |